> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pediatric Panel to Discuss Safety Reviews
- URL: https://www.fdaweb.com/pediatric-panel-to-discuss-safety-reviews/
- Published: 2016-08-17T12:00:00.000Z
- Updated: 2026-09-14T21:25:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136545

*Federal Register* Notice: FDA will hold a meeting of the Pediatric Advisory Committee 9/14, from 8 a.m. to 5:30 p.m. at DoubleTree by Hilton Hotel Bethesda-Washington DC, 8120 Wisconsin Ave., Bethesda, MD. The panel will discuss pediatric-focused safety reviews, as mandated by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. These products include Delzicol, Doryx, Kepivance, Sustiva, and Topamax. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-08-17/pdf/2016-19589.pdf?ref=fdaweb.com)